Literature DB >> 11755403

Structure of cephalosporin acylase in complex with glutaryl-7-aminocephalosporanic acid and glutarate: insight into the basis of its substrate specificity.

Y Kim1, W G Hol.   

Abstract

BACKGROUND: Semisynthetic cephalosporins are primarily synthesized from 7-aminocephalosporanic acid (7-ACA), which is obtained by environmentally toxic chemical deacylation of cephalosporin C (CPC). Thus, the enzymatic conversion of CPC to 7-ACA by cephalosporin acylase (CA) would be of great interest. However, CAs use glutaryl-7-ACA (GL-7-ACA) as a primary substrate and the enzyme has low turnover rates for CPC.
RESULTS: The binary complex structures of CA with GL-7-ACA and glutarate (the side-chain of GL-7-ACA) show extensive interactions between the glutaryl moiety of GL-7-ACA and the seven residues that form the side-chain pocket. These interactions explain why the D-alpha-aminoadipyl side-chain of CPC yields a poorer substrate than GL-7-ACA.
CONCLUSIONS: This understanding of the nature of substrate specificity may be useful in the design of an enzyme with an improved performance for the conversion of CPC to 7-ACA. Additionally, the catalytic mechanism of the deacylation reaction was revealed by the ligand bound structures.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11755403     DOI: 10.1016/s1074-5521(01)00092-8

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  11 in total

1.  Improving the activity and stability of GL-7-ACA acylase CA130 by site-directed mutagenesis.

Authors:  Wei Zhang; Yuan Liu; Huabao Zheng; Sheng Yang; Weihong Jiang
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

2.  Overexpression of penicillin V acylase from Streptomyces lavendulae and elucidation of its catalytic residues.

Authors:  Jesús Torres-Bacete; Daniel Hormigo; Raquel Torres-Gúzman; Miguel Arroyo; María Pilar Castillón; Luis José García; Carmen Acebal; Isabel de la Mata
Journal:  Appl Environ Microbiol       Date:  2015-02       Impact factor: 4.792

3.  Systematic optimization model and algorithm for binding sequence selection in computational enzyme design.

Authors:  Xiaoqiang Huang; Kehang Han; Yushan Zhu
Journal:  Protein Sci       Date:  2013-06-06       Impact factor: 6.725

4.  Evaluation of active designs of cephalosporin C acylase by molecular dynamics simulation and molecular docking.

Authors:  Qing Li; Xiaoqiang Huang; Yushan Zhu
Journal:  J Mol Model       Date:  2014-06-17       Impact factor: 1.810

5.  The N-terminal nucleophile serine of cephalosporin acylase executes the second autoproteolytic cleavage and acylpeptide hydrolysis.

Authors:  Jun Yin; Zixin Deng; Guoping Zhao; Xi Huang
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

6.  Evolution of an acylase active on cephalosporin C.

Authors:  Loredano Pollegioni; Simona Lorenzi; Elena Rosini; Giorgia Letizia Marcone; Gianluca Molla; Roberto Verga; Walter Cabri; Mirella S Pilone
Journal:  Protein Sci       Date:  2005-10-31       Impact factor: 6.725

Review 7.  Nonribosomal peptide synthetase biosynthetic clusters of ESKAPE pathogens.

Authors:  Andrew M Gulick
Journal:  Nat Prod Rep       Date:  2017-08-02       Impact factor: 13.423

8.  Improvement of the glutaryl-7-aminocephalosporanic acid acylase activity of a bacterial gamma-glutamyltranspeptidase.

Authors:  Chiaki Yamada; Kyoko Kijima; Sayaka Ishihara; Chinatsu Miwa; Kei Wada; Toshihiro Okada; Keiichi Fukuyama; Hidehiko Kumagai; Hideyuki Suzuki
Journal:  Appl Environ Microbiol       Date:  2008-04-04       Impact factor: 4.792

9.  Modelling of substrate access and substrate binding to cephalosporin acylases.

Authors:  Valerio Ferrario; Mona Fischer; Yushan Zhu; Jürgen Pleiss
Journal:  Sci Rep       Date:  2019-08-27       Impact factor: 4.379

10.  Initial insight into the function of the lysosomal 66.3 kDa protein from mouse by means of X-ray crystallography.

Authors:  Kristina Lakomek; Achim Dickmanns; Matthias Kettwig; Henning Urlaub; Ralf Ficner; Torben Lübke
Journal:  BMC Struct Biol       Date:  2009-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.